Abstract-Wound healing is a highly evolved defense mechanism against infection and further injury. It is a complex process involving multiple cell types and biological pathways. Mammalian adult cutaneous wound healing is mediated by a fibroproliferative response leading to scar formation. In contrast, early to mid-gestational fetal cutaneous wound healing is more akin to regeneration and occurs without scar formation. This early observation has led to extensive research seeking to unlock the mechanism underlying fetal scarless regenerative repair. Building upon recent advances in biomaterials and stem cell applications, tissue engineering approaches are working towards a recapitulation of this phenomenon. In this review, we describe the elements that distinguish fetal scarless and adult scarring wound healing, and discuss current trends in tissue engineering aimed at achieving scarless tissue regeneration.
INTRODUCTION
Wound healing is an elaborate process that occurs in three distinct yet overlapping phases-inflammation, cell proliferation, and remodeling. 74, 124 The final outcome of the healing process varies based on the developmental stage of the injured organism and the tissue type damaged. In 1979, Rowlatt reported that human fetal wound healing did not cause scar formation. 115 Since then, numerous studies have validated this finding by demonstrating that mammalian cutaneous wounds in early to mid-gestational fetal skin, unlike similar wounds in adult skin, heal by regeneration without scarring (Fig. 1) .
Adult cutaneous wound repair is characterized by the fibroproliferative response, a highly evolved process that quickly restores the skin barrier, thereby reducing the risk of infection and further injury. However, this response does have drawbacks as it is accomplished through incomplete regeneration of the original tissue and an overproduction of poorly organized collagen. The resulting scar tissue has less than 80% of the tensile strength of the original tissue and is further characterized by a flattened epidermis and loss of dermal appendages, including hair follicles and sebaceous glands. 52, 124 Additionally, aberrations in the fibroproliferative response can lead to pathological scarring. Pathologic scars, most commonly either hypertrophic or keloid in nature, are characterized by an excessive deposition of collagen, sometimes beyond the boundary of the original wound. The additional deposit of collagen may result in the formation of a prominent scar that is further complicated by pain and itching. 25 This fibrotic response has significant clinical implications, as it can restrict growth in the pediatric population 24 and even impair movement when occurring across joints. In addition, there are psychosocial ramifications associated with scar formation, as even small changes in scar appearance can significantly impact patient quality of life. 1, 7, 40, 80 Burn injuries, in particular, illustrate the debilitating effects of fibrotic tissue and the limitations of currently available treatments.
Extensive damage from burns and resultant scarring necessitate painful and costly surgeries, sometimes over many years, to restore limited functionality. 7, 40 In contrast, early to mid-gestational mammalian fetuses are able to heal without scar formation. Due in part to greater cellular mobility, fetal wound healing proceeds at a faster rate than adult healing and results in complete regeneration of the dermis, including epidermal appendages, without fibrosis. This mechanism is preserved across a number of mammalian species, including humans. 1, 2, 80 Moreover, the transition from fetal scarless wound healing to post-natal fibrotic healing occurs at a specific gestational age, 25 typically at around 18 days gestation (E18.5) in mice (term = E22) 32 and 24 weeks gestation in humans. Although the factors responsible for the fetal wound healing phenotype were originally attributed to the intrauterine environment, this has since been shown to be neither necessary nor sufficient for scarless healing. 79 The capacity for regeneration is now believed to be intrinsic to the tissue itself, and is closely associated with fetal dermal constitution. Differences in extracellular matrix (ECM) components, functional gene expression, cytokine and growth factor release, signal transduction and the inflammatory response have all been implicated in the differential healing outcomes between fetuses and adults (Table 1) . Herein, we review the fundamental differences between scarless fetal wound regeneration and scarring adult wound repair, with a focus on the inflammatory response and ECM synthesis, deposition and remodeling. We also discuss recent advances in tissue engineering that seek to replicate regeneration by utilizing bioengineered scaffolds and stem cell applications.
FETAL VS. ADULT WOUND HEALING

Inflammatory Response
Inflammatory Cells
The inflammatory response heralds the initiation of the wound healing process. After injury, inflammation is instigated by the recruitment of several circulating cell types. Inflammation in both the fetus and adult entail the release of transforming growth factor b1 (TGF-b1), platelet-derived growth factor (PDGF), tumor necrosis factor-a (TNF-a) and interleukin-1 (IL-1) by activated platelets. These cytokines act to recruit neutrophils into the wound to initiate debridement and to upregulate adhesion molecule expression. 102 Interestingly, fetal wound healing involves a reduced expression of neutrophil adhesion molecules compared to adult wound healing, 96 with subsequently decreased neutrophil migration into the fetal wound. 102, 119 Furthermore, neutrophil infiltration in adult wounds is typically followed by the arrival of macrophages 119 responsible for: further debridement of the wound; secretion of cytokines such as colony stimulating factor-1 (CSF-1), TNF-a, and PDGF; perpetuation of the inflammatory phase 119 ; and an increase in the fibrotic response. 112 In contrast, macrophage recruitment is almost nonexistent in murine fetal wounds before E14.5. This phenomenon is potentially mediated by a markedly reduced expression of TGF-b1 125 in combination with increased expression of TGF-b3 12, 19 in fetal wounds. Transgenic neonatal mice lacking macrophages demonstrate minimal fibrosis during wound healing, supporting the argument that macrophages play an important role in scar formation. 119 Finally, mast cells enter the adult wound environment in response to IL-33 83 and release TNF-a. TNF-a acts to recruit additional neutrophils, promote the fibroblast to myofibroblast transition, and enhance the activity of matrix metalloproteinases (MMPs). Mast cells therefore govern tissue remodeling, the final phase of wound healing. It is worth noting that mast cells are deficient in fetal wounds. This is believed to further contribute to the overall decreased inflammatory response seen in fetal wounds, and corresponds with a reduction in the secretion of inflammatory factors such as histamine, TGF-b, TNF-a, and vascular endothelial growth factor (VEGF). 145 
Inflammatory Cytokines
Inflammatory cytokines play an important role throughout the different phases of wound healing. These cytokines predominantly consist of members of the TGF-b family, interleukins, and VEGF. In parallel with the previously described observation that adult wounds attract greater numbers of inflammatory cells, adult wounds have also been found to express higher levels of inflammatory factors in comparison to fetal wounds.
For instance, adult wounds have been demonstrated to express higher levels of TGF-b1 and 2, and lower levels of TGF-b3 than fetal wounds. TGF-b1 acts as a chemotactic agent for neutrophils, monocytes, and fibroblasts, which in turn express additional TGF-b1 in a positive feedback mechanism. TGF-b3 expression is linked to hypoxia 121 and is thought to keep fetal cells in a relatively undifferentiated state with a blunted inflammatory response, promoting scarless regeneration. 12 Interleukins, another important component of the signaling cascade for wound repair, are also present at different levels in fetuses and adults. Interleukin-6 and -8 (IL-6 and -8) are both pro-inflammatory cytokines that are increased in adult wound healing. 71, 119 Conversely, interleukin-10 (IL-10), an anti-inflammatory cytokine that allows for organized collagen deposition, is almost absent in adult wounds but highly expressed in fetal wounds. 105 Lastly, VEGF, a growth factor and one of the major regulators of neovascularization through promotion of endothelial cell proliferation and angiogenesis, has been associated with the development of hypertrophic and keloid scarring. 6, 87, 94, 134, 141 Correspondingly, fetal wounds express lower levels of VEGF. In summary, fetal wounds have a muted vascular response 119 in addition to reduced inflammation and subsequently display decreased scar formation. 142 
Extracellular Matrix
Once thought to be an inert substance, the ECM, has been identified as a dynamic network of fibrous adhesion proteins, proteoglycans, and glycosaminoglycans (GAGs) critical to wound repair after injury. For instance, the rate at which wound matrix proteins are deposited is a key feature that distinguishes fetal wound regeneration from adult wound repair. Additionally, 
Collagen
Collagen is the dominant structural component of mammalian connective tissue. There are over 20 different types of collagen in humans, with types I-IV being the most abundant. Type I collagen is the primary collagen found in fetal and adult skin, and together with type III collagen provide tensile strength to skin. Studies have demonstrated that there are distinct variations in the collagen-type profile and cross-linking patterns of collagen in fetal skin and wounds compared to their adult counterparts. These findings have many implications for the role of collagen in wound regeneration.
Fetal skin contains a greater proportion of type III collagen, whereas adult skin consists of predominantly type I collagen. As the fetus develops, the collagen profile of the skin transitions to the post-natal adult phenotype with an increased type I to type III ratio. This transition correlates with the shift from scarless repair to scar formation. 17, 76, 93 The patterns of collagen deposition in fetal and adult wounds undergoing repair also differ markedly. Fetal skin, with higher concentrations of the smaller and finer type III collagen, regenerates collagen fibers in a fine, well-organized reticular pattern that closely resembles the collagen architecture of uninjured skin. In contrast, skin wounds that have acquired the adult phenotype contain densely arranged collagen bundles that are oriented parallel to the wound surface. Additionally, collagen cross-linking increases with gestational age, leading to a parallel increase in matrix rigidity and scar formation. 82 Studies in fetal lambs suggest that these differences in collagen deposition contribute significantly to scarless repair. 76 However, variations in fetal and adult collagen production may be secondary to interactions between specific cell surface receptors on the fibroblasts. Collagen fibers bind to discoid domain receptors (DDRs), a family of tyrosine kinases that regulate cell proliferation, differentiation, and wound healing. DDR-1 is increasingly expressed on cell surfaces of early gestational fetal fibroblasts but decreases with gestational age. 30 The variable expression of cell surface receptor DDR-1 may modulate collagen production and contribute to the remarkable properties of scarless fetal wound regeneration. 16 
Fibroblasts
Fibroblasts are an additional vital factor to successful wound repair. They perform many key roles, including deposition of ECM and generation of appropriate response to endogenous stimuli such as growth factors. Alterations in fibroblast performance of any of those roles could significantly impact wound healing outcomes.
Fetal fibroblasts in vitro have been found to synthesize more total collagen. Not surprisingly, they also synthesize a higher proportion of type III and IV collagen in comparison to adult fibroblasts. As previously mentioned, experimental evidence has indicated that there are different type I to III collagen ratios at different stages of fetal development. During early gestation, fetal fibroblasts exhibit a higher rate of prolyl hydroxylase (the rate-limiting enzyme in collagen synthesis) activity than in late-gestational fetal or adult fibroblasts. 16 Fibroblasts from mid-gestation (E15) fetal mice also demonstrate decreased expression of pro-collagen 1a1, indicating lower rates of type I collagen synthesis. In contrast, fibroblasts from late gestation (E18) showed increased pro-collagen 1a1 expression with decreased pro-collagen 3 expression, 23 demonstrating upregulation of type I collagen synthesis and decreased type III collagen synthesis with advancing gestational age.
Fetal fibroblasts have also been observed to migrate to the wound site at a faster rate than adult fibroblasts. Fetal fibroblasts have the ability to both proliferate and synthesize collagen simultaneously at the wound site. In contrast, adult fibroblasts need to divide prior to laying down collagen, leading to delayed wound healing. 67 As a whole, delayed migration velocity and differing rates of collagen deposition in adult wound healing are believed to be major contributing factors to scar formation.
Adult fibroblast lineage now has a better understood impact on repair outcome. Myofibroblasts, a specialized group of contractile fibroblasts that have acquired smooth muscle a-actin, are present in adult wounds early in the post-injury period. Scarless wounds have virtually no myofibroblasts, whereas in adult wounds the number of active myofibroblasts correlate directly with contraction and the degree of scarring. 41 Mechanistically, the contractile forces generated by myofibroblasts are thought to contribute to scar formation by altering the orientation of collagen fibrils.
Distant fibroblast lineages within the dermis are now known to impact scar formation and hair follicle formation. In contrast, reticular dermal fibroblasts are responsible for much of the scar deposition found during repair. 37 During adult wound repair, the early deposition of collagen and ECM is performed by reticular fibroblasts, which are thought to be responsible for scarring. 37 
Hyaluronic Acid and Wnt
The abundance of GAGs, particularly HA, is another distinguishing feature of the fetal dermis and wound matrix. 66, 91 HA is a linear GAG containing disaccharide units of alpha-1,4-D-glucuronic acid and beta-1,3-N-acetyl-D-glucosamine.
The molecular weight of HA ranges from 10 25 to 10 7 Da. 122 It plays an important role in the structure of ECM and is present in high concentrations and thought to exert influence during rapid cell proliferation, motility, and de-differentiation.
HA is deposited early in the course of both fetal and adult wound repair, but a sustained deposition occurs more rapidly during fetal wound regeneration. In adult wound repair, HA increases much more slowly. 77 Consistent with this observation, fetal wounds have also been found to contain a larger amount of HA-stimulating activity (HASA) than adult wounds, with HA and HASA in fetal lamb wound fluid shown to decrease significantly during the transition period from scarless to scarring wound repair. 75 The balance between HA synthesis and degradation governs its levels in the dermis. Hyaluronan synthases (HASs) are responsible for HA production in response to inflammatory cytokines 64 while the degradation of HA is controlled by hyaluronidases, in particular hyaluronidase-2 (Hyal2). Interestingly, the wingless proteins (Wnts), which are involved in both dermal and epidermal development 8 and are differentially regulated post-injury in fetal and adult dermis, 33, 101 appear to regulate HA levels in the dermis. Fetal and adult wounds differentially express the hyaluronan synthase genes (HAS1-3), each of which transcribes an enzyme with unique characteristics in their production of HA. 59, 126, 127 Under the influence of either Wnt3a or TGF-b1, fetal fibroblasts increase expression of HAS2 and 3 while post-natal fibroblasts down-regulate both HAS2 and 3. Hyal2 expression, however, is increased by Wnt3a in post-natal fibroblasts but not fetal fibroblasts. 22 The higher level of HAS expression and decreased Hyal expression in fetal dermis compared to adult, under the influence of Wnt signaling, underscores the role of HA deposition in scarless healing.
HA also plays a role in collagen synthesis. Fetal fibroblasts have 2 to 4-fold more surface HA receptors than their adult counterparts. 4 The higher concentration of HA receptors serve to enhance fibroblast migration without compromising fibroblast HA production. In fetal wounds this results in increased type III collagen deposition along with non-collagen ECM proteins, 76, 90 and subsequently accelerated wound repair.
Proteoglycans
Another source of investigatory interest is the heterogeneous group of polyanionic macromolecules, specifically small leucine-rich proteoglycans (SLRPs), which covalently bind to linear sulfated GAG chains. SLRPs such as decorin, chondroitin sulfate and fibromodulin are abundantly expressed in connective tissues and ECM. Decorin production increases by 72% during the transitional period from scarless to scarring healing in fetal rat skin and continues to increase into the post-natal period, achieving a level that is 300 times that of early gestational fibroblasts. 13 In contrast, chondroitin sulfate proteoglycan is present within fetal mouse wounds during collagen fibril formation, but is absent at that time in adult mouse wounds. 139 Thus, chondroitin sulfate is likely to play a role in regeneration, whereas other sulfated GAGs that are more prevalent in adult wounds, such as decorin, may be important for scar formation. Fibromodulin, another proteoglycan abundantly present in fetal ECM, inhibits collagen fibrillogenesis. Fibromodulin binds and inactivates TGF-b and has an anti-scarring effect during wound healing. 125 Fibromodulin production decreases with maturation and its facilitated cellular migration is decreased in adult wounds but remains unchanged in fetal wounds.
Adhesion Proteins
The amount of ECM adhesion proteins and cellular surface receptors differ between fetal and adult wound healing. Production of cell adhesion proteins, fibronectin and tenascin, increases dramatically early in the fetal wound regenerative process and is present in greater amounts in fetal wounds. These proteins mediate cellular attachment to the ECM and attract fibroblasts, keratinocytes, and endothelial cells to sites of injury.
In early gestational fetal wounds, fibronectin is synthesized within 4 h after wounding, whereas in adult wounds fibronectin expression does not occur until 12 h after injury. 78, 139 Similarly, tenascin is deposited more rapidly in fetal wounds than in adult wounds. 140 This rapid deposition of fibronectin and tenascin stimulates early cell attachment and migration, respectively. Together, this promotes the formation of an organized wound matrix that results in skin regeneration.
Early gestational fetal wounds are also characterized by rapid increases in epidermal integrin receptors that bind fibronectin and tenascin in the provisional matrix. A greater proportion of activated fetal keratinocytes near the wound edge express these receptors and higher per cell receptor expression is present in fetal wounds within the first 4 h of injury. This rapid integrin up-regulation is believed to facilitate fetal keratinocyte proliferation and migration resulting in prompt epidermal repair. 26 
Metalloproteinases
The composition and organization of ECM is modulated by the balance between matrix metalloproteinases (MMPs) and tissue-derived inhibitors of metalloproteinases (TIMPs). During wound repair, their expression is tightly regulated. MMPs are a family of zinc-dependent proteinases that have been implicated in ECM remodeling and wound healing, specifically, MMP-1 (collagenase-1), MMP-2 (gelatinase A), MMP-3 (stromelysin-1), MMP-7 (matrilysin), MMP-8 (collagenase-2), MMP-9 (gelatinase B), and MMP-10 (stromelysin-2). 86, 104 The proteolytic activity of MMPs is inhibited by 4 distinct TIMPs.
Different expression and temporal changes of specific MMPs and TIMPs have been found in fetal wound regeneration and adult wound repair. Scarless fetal wounds have a higher ratio of MMP to TIMP expression in comparison to adult wounds. The greater presence of activated MMPs indicates that the fetal healing process favors remodeling over accumulation of collagen. 34 The relative activity of MMP and TIMP is thus crucial not only to the determination of the composition of the wound matrix but also the healing outcome.
Tissue Engineering in Wound Healing
Biomaterials and Scaffolds
The ECM, as discussed in detail above, is a critical determinant in regulating regeneration vs. repair. With growing awareness of the importance of ECM in wound healing, engineering approaches using ECMmimetic materials to construct scaffolding for the delivery of therapeutic cells have become increasingly popular. Modeled after the ECM, scaffolds provide a suitable environment for cell delivery, wound support, and guidance for tissue regeneration. In this section, we discuss the current trends in materials utilized for scaffold production ( Table 2 ). The ideal matrix is biocompatible without toxicity, promotes regeneration and cellular incorporation, and fully incorporates into the recipient tissue site. The following materials each have distinct advantages and disadvantages that are being explored through experimentation.
Collagen
Collagen has great biocompatibility and is absorbable. Hence, it is the gold standard for wound healing. Collagens are the most abundant proteins in the body and are the major components in bone, cartilage, skin, ligament, and tendon. Since collagen has similar properties and structure as the natural ECM, it is a reasonable scaffold material for regenerative therapies. 81 Collagen-based scaffolds have been tested in the repair of cartilage, 45, 128, 129 skin, 3,108 and bone. 63, 117, 146, 147 There are currently several collagenbased devices on the market. Promogram, BICOL, and Puraply are all collagen-based applications for wound protection, wound site support, ulcer protection, and tissue regeneration. 29, 81, 116 Unfortunately, the majority of these scaffolds are not comprised of the fetal Collagen I/III ratio and therefore are not ideally suited to reciprocate the fetal dermis and promote scarless wound healing.
Hyaluronic Acid
Hyaluronic acid is an important polysaccharide present in connective tissues such as the skin and tendon. HAs have good biocompatibility and can be readily digested by hyaluronidases in the body. 122 As a major component of ECM and described above as particularly prominent in fetal dermis, HA scaffolds represent an attractive option for regenerative healing and are being developed for cartilage regeneration and wound healing. 54, 73 Hyaff, Hycoat, and Laser skin are current HA-based commercial devices.
Fibrin
Fibrin is a glycoprotein present in the blood. It is the product of the thrombin enzymatic cleavage of fibrinogen during coagulation. Fibrin is a major component in blood clots, which are crucial for reparative wound healing and limiting blood loss. Fibrin gels can be made from a patient's own blood and used as an autologous scaffold. This allows the avoidance of potential problems such as immune response and transmission of blood-borne diseases. Fibrin is currently used as a medical sealant and glue. For example, Tisseel, Beriplast, and Biocol, all fibrin-based products, are used extensively in surgery. Due to its excellent biocompatibility, fibrin scaffolds have been fabricated for use in mesenchymal stem cell transplantation, 14 preserving cardiac function, 31 bone tissue regeneration, 103, 106 and neural fiber sprouting. 62 From the perspective of achieving scarless, regenerative repair, though, fibrin is associated with adult, reparative healing and does not represent an appropriate scaffold to reciprocate fetal healing.
Chitosan
Chitosan is a natural linear aminopolysaccharide with a unique chemical structure and composition. Chitosan is produced from N-deacetylation of chitin, which is found in the exoskeleton of insects, shellfishes, and fungus. 109, 111 In biomedical application, chitosan usually contains less than 50% D-acetyl-D-glucosamine in its structure. 111 Chitosan can be degraded by lysozyme. 132 Chitosan has been used in tissue engineering and drug delivery because of its biocompatibility and biodegradability. In regenerative medicine, porous chitosan has been tested for tissue engineering, 85 cartilage tissue engineering, 44,51,99 skin tissue engineering, 84 and orthopedic tissue engineering. 35 Chitosan may represent a useful addition to the ideal regenerative scaffold when combined with HA and the appropriate ratio of collagen types.
Acellular Matrix
Acellular matrix is derived from animal tissue through the removal of living cells. 143 It has been developed and applied in surgery for reconstruction. 72 There are many advantages to this matrix. It is biocompatible and biodegradable since it originates from living tissue. Also, it remains morphologically identical to natural tissue structure, which provides a preferred environment or blueprint for cellular migration and proliferation. Furthermore, the mechanical property of this matrix is similar to the adjacent environment. 143 The acellular dermal matrix (ADM) allograft has been used for treating burns, 136 urethral repair, 29 and dermis reconstruction. 72, 137, 150 One of the better characterized and validated ADMs is OASIS Wound Matrix, derived from submucosal layers of porcine jejunum. 11 It has demonstrated significant wound healing advantages in clinical trials compared to conventional therapy 95, 113 and alternative regenerative scaffolds. 100, 114 Its efficacy may be related to its growth factor content, which includes basic fibroblast growth factor (bFGF) 53 and transforming growth factor-beta 1 (TGF-b1). 92 AlloDerm, DermaMatrix, and Flex HD are other current commercially available acellular matrices, but are all from adult tissue. Available acellular fetal dermal matrices are bovine in origin, including PriMatrix and SurgiMend, though their clinical efficacy is uncertain 48, 138 and their ability to promote scarless healing has not been investigated.
Synthetic Biodegradable Polymers
The most common synthetic biodegradable material used for tissue engineering includes polyesters such as polycaprolactone, polyglycolide, polylactic acid, poly(lactic-co-glycolic acid) 18 and their copolymers. Compared to natural materials, synthetic polymers have the advantage of mechanical strength, processability, controllable degradation rate, and adjustable physical properties. These polyesters can be degraded by hydrolysis under physiological conditions. The degraded products can then be safely metabolized or reabsorbed by the body. These polymers can be fabricated into various scaffolds including fibers by electrospinning, 36, 50, 70, 148, 149 porous scaffolds by saltleaching, 56, 110 and 3D scaffolds by soft lithography stamping 47 or solid free-form fabrication. 58, 130 Numerous studies have demonstrated the feasibility of biodegradable polyester scaffolds. 55, 69, 110, 135 Dermagraft is a knitted mesh medical device comprised of polyglycolic and polylactic acid that is currently in use for treatment of chronic diabetic foot ulcers. 88 While not biodegradable, poly(butyl methacrylate-co-methacrylic acid) is of interest when considering materials for scaffold design, promoting angiogenic ingrowth 18 and accelerating diabetic wound healing, 89 presumably by promoting Shh signaling. 43 
Regenerative Scaffolds
Our understanding of fetal ECM composition should inform the development of scaffolds capable of regenerative, scarless healing. McDevitt's group described an approach involving the use of acellularized ECM produced by embryonic stem cells (ESCs) as regenerative matrix. 97 Interestingly, murine ESCs synthesized hyaluronan and expressed HAS2 as part of their ECM, 123 consistent with the fetal dermis. An alternative approach described by Uijtdewilligen et al. involves the incorporation of molecules identified to be upregulated during embryonic skin development, including hyaluronan, into a type I collagen-heparin scaffold. 133 Though McDevitt's group have not yet assessed the regenerative potential of ESC produced ECM and Uijtdewilligen et al. employed only type I collagen and should have prioritized type III collagen, in the authors opinions, these approaches represents a significant step towards recapitulation of the fetal dermal environment.
Stem Cells in Wound Healing
Advances in tissue engineering have enhanced feasibility and efficacy of cell-based therapies as improved cell delivery methods increase the effectiveness of therapeutic cell transplants. The ultimate goal of such therapy would be the utilization of a cell-seeded scaffold to recapitulate fetal wound regeneration (Fig. 2) . Stem cells are a cell source of particular interest as they play a key role in tissue regeneration during wound healing. 68 Stem cells provide daughter cells that replenish lost or injured tissue directly through differentiation and/or recruit inflammatory and tissue progenitor cells through paracrine signaling.
10,28 For many years, mesenchymal stem cells derived from bone marrow (BM-MSCs) were the main donor cells used in tissue engineering research. 20, 21, 107 Thus, the majority of cell-based regenerative studies have focused on BM-MSCs. More recently, however, adipose-derived stem cells (ASCs) have been increasingly utilized due to the ease with which adipose tissue can be harvested and the abundance of therapeutic stem cells found in adipose tissue. 120 
Mesenchymal Stem Cells
Although MSCs can be found in a variety of tissue, much of the wound healing literature to date has focused on BM-MSCs. These cells are considered attractive for regenerative therapy as endogenous MSCs have the ability to migrate to the site of injury and play an active role in wound healing. 60 Several preclinical studies have demonstrated the ability of MSCs to accelerate wound closure. Using the excisional wound healing model 46 with a variety of delivery methods (topical, local and systemic injection, and collagen scaffold), numerous studies have demonstrated enhanced cutaneous wound repair with MSCs in both wild-type and diabetic mice. 27, 28, 39, 61, 118, 144 Falanga et al. 42 was able to prevent ulceration and accelerate wound closure in mice by spraying autologous BM-MSCs with a mixture of fibrin and thrombin into wounds. The same method applied in a small human clinical trial was found to accelerate wound closure and resurfacing without adverse effects. Additionally, in chronic wounds there was a strong correlation between reduction in ulcer area and number of BM-MSCs applied to the wound. 42 Another small clinical trial examined the topical application of culture expanded autologous BM-MSCs on chronic ulcers unresponsive to prior treatment. Investigators were able to achieve wound closure with increased cellularity and dermal rebuilding 9 with application of BM-MSCs. Although these studies show great promise, confirmation of initial observations in larger clinical trials as well as the development of less invasive harvesting techniques are necessary for the full transition of BMMSCs from bench to bedside.
Adipose-Derived Stem Cells
In recent years, ASCs have become an increasingly attractive donor cell source for cell-based therapy because they can be readily obtained in large numbers through minimally invasive techniques with low donor-site morbidity 131 and are abundantly present in stroma tissue, negating the need for expansion in culture. Moreover, ASCs secrete a wide range of growth factors involved in wound healing in a regulated manner. Studies have also shown that ASCs remain viable at the wound site over significant periods of time 15, 38, 65 and have the ability to differentiate into epidermal and endothelial cells as well as dermal fibroblasts. 5 In a recent study utilizing the excisional wound healing model in mice, Kim et al. 65 delivered a collagen gel solution with ASCs to cutaneous wounds. These results revealed that application of ASCs led to a significant reduction of wound size with accelerated reepithelialization. A separate study in which acellular dermal matrix was seeded with ASCs, then applied to the same model similarly demonstrated accelerated wound closure. 57 Yet another study found that the application of ASCs overexpressing VEGF accelerated wound healing in comparison to unmodified ASCs. 98 The results from these studies all attest to the potential for the use of ASCs in cell-based regeneration.
CONCLUSION
Fetal skin possesses the unique ability to regenerate after wounding, with emerging research linking this ability to multiple aspects of the wound environment. Specific differences in the fetal and adult inflammatory and cell response, cytokine and growth factor expression profiles, and ECM composition have been all identified. Our increased understanding of the fetal tissue regeneration process has led to a variety of promising translational approaches attempting to recapitulate this environment. Less well understood are the cell populations, particularly fibroblasts, involved in fetal vs. adult healing and their relevance to the scarless to scarring transition. Exciting developments, such as new transgenic mouse models and high throughput single cell analysis 49 should facilitate an interrogation of these cell populations. Future work should be aimed at improving our understanding of the fetal wound environment and the cell populations involved in addition to leveraging our current understanding to develop biomaterials that more closely recapitulate this environment.
The approach described by Uijtdewilligen et al.
133
highlights the potential to incorporate ECM proteins and growth factors reflective of the fetal milieu into tissue engineering scaffolds. As previously mentioned, increased fibroblast proliferation and migration with rapid wound healing is characteristic of the fetal regenerative response and the increased cellularity and rate of wound closure achieved through stem cell based therapies, whether BM-MSCs or ASCs, partially recapitulates the fetal response to injury. This enhanced healing is largely linked to secretion of growth factors and cytokines, which can be overexpressed. 
